Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth (Status and Outlook) 2024-2031

Report ID: 1158371 | Published Date: Sep 2024 | No. of Page: 104 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2028
        2.1.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type
        2.2.1 Paracetamol
        2.2.2 Ibuprofen
        2.2.3 Aspirin
        2.2.4 Naproxen
        2.2.5 Others
    2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
        2.3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)
    2.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application
        2.4.1 Hospital Pharmacies
        2.4.2 Retail Pharmacies
        2.4.3 Online Pharmacies
    2.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
        2.5.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)
3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Player
    3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Players
        3.1.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2020-2022)
        3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2020-2022)
    3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Regions
    4.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2017-2022)
    4.2 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth (2017-2022)
    4.3 APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth (2017-2022)
    4.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth (2017-2022)
    4.5 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
    5.2 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022)
    5.3 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022)
    6.2 APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022)
    6.3 APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Country (2017-2022)
    7.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022)
    7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Region (2017-2022)
    8.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022)
    8.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
    10.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Regions (2023-2028)
        10.1.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Regions (2023-2028)
        10.1.2 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast
        10.1.3 APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast
        10.1.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast
        10.1.5 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast
    10.2 Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Country (2023-2028)
        10.2.1 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.2.2 Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.2.3 Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.2.4 Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
    10.3 APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Region (2023-2028)
        10.3.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.3.2 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.3.3 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.3.4 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.3.5 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.3.6 Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
    10.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Country (2023-2028)
        10.4.1 Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.4.2 France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.4.3 UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.4.4 Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.4.5 Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
    10.5 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Region (2023-2028)
        10.5.1 Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.5.2 South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.5.3 Israel Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.5.4 Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
        10.5.5 GCC Countries Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast
    10.6 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Type (2023-2028)
    10.7 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Novartis
        11.1.1 Novartis Company Information
        11.1.2 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Novartis Main Business Overview
        11.1.5 Novartis Latest Developments
    11.2 Pfizer
        11.2.1 Pfizer Company Information
        11.2.2 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Pfizer Main Business Overview
        11.2.5 Pfizer Latest Developments
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Company Information
        11.3.2 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Boehringer Ingelheim Main Business Overview
        11.3.5 Boehringer Ingelheim Latest Developments
    11.4 Teva Pharmaceutical
        11.4.1 Teva Pharmaceutical Company Information
        11.4.2 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Teva Pharmaceutical Main Business Overview
        11.4.5 Teva Pharmaceutical Latest Developments
    11.5 Hospira
        11.5.1 Hospira Company Information
        11.5.2 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Hospira Main Business Overview
        11.5.5 Hospira Latest Developments
    11.6 Lonza Group
        11.6.1 Lonza Group Company Information
        11.6.2 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Lonza Group Main Business Overview
        11.6.5 Lonza Group Latest Developments
    11.7 Mylan
        11.7.1 Mylan Company Information
        11.7.2 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Mylan Main Business Overview
        11.7.5 Mylan Latest Developments
    11.8 Aurobindo Pharma
        11.8.1 Aurobindo Pharma Company Information
        11.8.2 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Aurobindo Pharma Main Business Overview
        11.8.5 Aurobindo Pharma Latest Developments
    11.9 Dr. Reddy's Laboratories
        11.9.1 Dr. Reddy's Laboratories Company Information
        11.9.2 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Dr. Reddy's Laboratories Main Business Overview
        11.9.5 Dr. Reddy's Laboratories Latest Developments
    11.10 Actavis
        11.10.1 Actavis Company Information
        11.10.2 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Actavis Main Business Overview
        11.10.5 Actavis Latest Developments
    11.11 Wuxi Apptec
        11.11.1 Wuxi Apptec Company Information
        11.11.2 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Wuxi Apptec Main Business Overview
        11.11.5 Wuxi Apptec Latest Developments
    11.12 Zhejiang NHU
        11.12.1 Zhejiang NHU Company Information
        11.12.2 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
        11.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Zhejiang NHU Main Business Overview
        11.12.5 Zhejiang NHU Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Paracetamol
    Table 3. Major Players of Ibuprofen
    Table 4. Major Players of Aspirin
    Table 5. Major Players of Naproxen
    Table 6. Major Players of Others
    Table 7. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)
    Table 10. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)
    Table 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Player (2020-2022)
    Table 15. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Products Offered
    Table 16. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Country (2017-2022)
    Table 23. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)
    Table 25. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)
    Table 27. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Region (2017-2022)
    Table 29. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)
    Table 31. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)
    Table 33. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Country (2017-2022)
    Table 35. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)
    Table 37. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    Table 46. Key Market Challenges & Risks of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    Table 47. Key Industry Trends of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    Table 48. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Novartis Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 55. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 56. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Novartis Main Business
    Table 58. Novartis Latest Developments
    Table 59. Pfizer Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 60. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 61. Pfizer Main Business
    Table 62. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Pfizer Latest Developments
    Table 64. Boehringer Ingelheim Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 65. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 66. Boehringer Ingelheim Main Business
    Table 67. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. Boehringer Ingelheim Latest Developments
    Table 69. Teva Pharmaceutical Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 70. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 71. Teva Pharmaceutical Main Business
    Table 72. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. Teva Pharmaceutical Latest Developments
    Table 74. Hospira Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 75. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 76. Hospira Main Business
    Table 77. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. Hospira Latest Developments
    Table 79. Lonza Group Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 80. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 81. Lonza Group Main Business
    Table 82. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. Lonza Group Latest Developments
    Table 84. Mylan Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 85. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 86. Mylan Main Business
    Table 87. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. Mylan Latest Developments
    Table 89. Aurobindo Pharma Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 90. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 91. Aurobindo Pharma Main Business
    Table 92. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Aurobindo Pharma Latest Developments
    Table 94. Dr. Reddy's Laboratories Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 95. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 96. Dr. Reddy's Laboratories Main Business
    Table 97. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. Dr. Reddy's Laboratories Latest Developments
    Table 99. Actavis Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 100. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 101. Actavis Main Business
    Table 102. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 103. Actavis Latest Developments
    Table 104. Wuxi Apptec Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 105. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 106. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 107. Wuxi Apptec Main Business
    Table 108. Wuxi Apptec Latest Developments
    Table 109. Zhejiang NHU Details, Company Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Area Served and Its Competitors
    Table 110. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Offered
    Table 111. Zhejiang NHU Main Business
    Table 112. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 113. Zhejiang NHU Latest Developments
List of Figures
    Figure 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type in 2021
    Figure 7. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Hospital Pharmacies
    Figure 8. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Hospital Pharmacies (2017-2022) & ($ Millions)
    Figure 9. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Retail Pharmacies
    Figure 10. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Retail Pharmacies (2017-2022) & ($ Millions)
    Figure 11. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Online Pharmacies
    Figure 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Online Pharmacies (2017-2022) & ($ Millions)
    Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021
    Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Player in 2021
    Figure 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Regions (2017-2022)
    Figure 16. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2022 ($ Millions)
    Figure 17. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2022 ($ Millions)
    Figure 18. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2022 ($ Millions)
    Figure 19. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2017-2022 ($ Millions)
    Figure 20. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Value Market Share by Country in 2021
    Figure 21. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Share by Type in 2021
    Figure 22. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021
    Figure 23. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 25. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 27. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Region in 2021
    Figure 28. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021
    Figure 29. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 33. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Country in 2021
    Figure 36. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type in 2021
    Figure 37. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021
    Figure 38. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 39. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 40. UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Region in 2021
    Figure 44. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Type in 2021
    Figure 45. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Market Share by Application in 2021
    Figure 46. Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 47. South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Israel Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 50. GCC Country Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Americas Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 52. APAC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 53. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 54. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 55. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 56. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 57. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 58. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 59. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 60. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 61. Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 62. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 63. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 64. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 65. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 66. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 67. UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 68. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 69. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 70. Spain Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 71. Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 72. South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 73. Israel Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 74. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
    Figure 75. GCC Countries Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Nonsteroidal Anti-Inflammatory Drugs Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Nonsteroidal Anti-Inflammatory Drugs Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Nonsteroidal Anti-Inflammatory Drugs Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports